Pain Therapeutics 2005: Market Dynamics and Outlook

• Publication date: May 2005

Pain Therapeutics 2005: Market Dynamics and Outlook provides detailed analysis and informationconcerning the global market for pain therapeutics, R&D pipelines and company involvement in thisfield.About one and a half billion people suffer from moderate to severe chronic pain worldwide andapproximately 50 million Americans suffer with pain. The value of the pharmaceutical market for painrelief reflects this seeming worldwide epidemic of ...

Pain Therapeutics 2005: Market Dynamics and Outlook provides detailed analysis and informationconcerning the global market for pain therapeutics, R&D pipelines and company involvement in thisfield.

About one and a half billion people suffer from moderate to severe chronic pain worldwide andapproximately 50 million Americans suffer with pain. The value of the pharmaceutical market for painrelief reflects this seeming worldwide epidemic of pain, with the overall value reaching nearly $23billion in 2004.

In this new report, key pain management therapeutics such as Cox-II inhibitors, opioids, triptans,anticonvulsants and traditional NSAIDs are discussed in terms of their past, present and future valueand the role they are playing in the effective management of pain.

The dynamics of this market have been altered greatly over the past year. The troubles surroundingthe multi-billion dollar Cox-II class has created a void in the marketplace. Pain Therapeutics 2005explains just what the Cox-II crisis means for the future of pain management and what kinds ofopportunities their failure may present for other classes of pain management medications.

Pain Therapeutics 2005 also analyzes the markets and provides forecasts for:

• the fast-growing anticonvulsant class
• migraine therapies
• traditional NSAIDs
• and opioids.

• 93 tables/graphs which provide the reader with valuable illustrated insight into trends and issues
affecting this growing market.
• Thorough financial breakdown of the leading products and companies making an impact on the pain
market
• Identification and discussion of trends and issues that are pushing the market into the future.
• Profiles of key companies involved in the development and marketing of pain therapeutics
• Forecasts of key products/classes

Global Drug And Medication Industry